MAPT and Alzheimer disease: Thomas et al. [69] agreed with this and stated that studied diabetic subjects (n = 69) suffered from at least 1 AD risk factor (e.g., cognitive decline, Aβ deposition, hyperphosphorylated tau, and genetic susceptibility).